Table 1.
Baseline characteristics.
| N (%) | ||
|---|---|---|
| All patients | 118 (100%) | |
| Gender | Female | 46 (39%) |
| Male | 72 (61%) | |
| Age, years | 55 (48–64) | |
| Etiology | ASH | 32 (27%) |
| NASH | 6 (5%) | |
| HBV | 17 (14%) | |
| HCV | 43 (36%) | |
| PBC | 3 (3%) | |
| AIH | 8 (7%) | |
| Toxic, non-alcohol | 2 (2%) | |
| Cirrhose cardiaque | 1 (1%) | |
| Kryptic | 1 (1%) | |
| Other | 5 (4%) | |
| Concomitant diseases | Diabetes mellitus | 31 (26%) |
| Chronic kidney disease | 24 (20%) | |
| Heart failure | 9 (8%) | |
| COPD | 8 (7%) | |
| Child–Pugh Score | 8 (7–10) | |
| Child A | 25 (21%) | |
| Child B | 51 (43%) | |
| Child C | 33 (28%) | |
| Missing data | 9 (8%) | |
| Ascites | No | 52 (44%) |
| Moderate | 14 (12%) | |
| Massive | 52 (44%) | |
| Encephalopathy | No | 99 (84%) |
| Grade I–II | 18 (15%) | |
| Grade III–IV | 1 (1%) | |
| Spleen length, cm | 13.7 (16.0–18.2) | |
| Laboratory values | Albumin, g/dL | 3.1 (2.7–3.5) |
| Bilirubin, mg/dL | 1.7 (0.9–3.9) | |
| INR | 1.4 (1.2–1.7) | |
| Creatinine, g/dL | 1.0 (0.7–1.6) | |
| LDH, U/L | 234 (185–299) | |
| Hemoglobin, g/dL | 9.6 (8.3–11.0) | |
| Erythrocytes, /pL | 3.3 (2.8–3.8) | |
| Leukocytes, /nl | 3.3 (2.2–4.9) | |
| Thrombocytes, /nl | 58 (37–82) | |
| Overall survival, months | 30 (12–82) |
Count data is shown for categorical variables. Continuous data are summarized by median value and inter-quartile range (IQR). ASH, alcoholic steatohepatitis; NASH, non-alcoholic steatohepatitis; HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cholangitis; AIH, autoimmune hepatitis; COPD, chronic obstructive pulmonary disease; INR, international normalized ratio; LDH, lactate dehydrogenase.